Ambrisentan
9 NDCs across 9 manufacturers|9 Generic,0 Brand
Ambrisentan is used to treat pulmonary hypertension, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Jun 15, 2007, and the first generic was approved Mar 28, 2019. FDA's Orange Book lists 16 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $268 million on Ambrisentan across 65,000 claims for 8,083 beneficiaries.
Ambrisentan is available as 9 NDCs from 9 manufacturers (9 generic, 0 brand), with NADAC prices from $8.02 to $8.02 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
9
9G / 0B
Manufacturers
9
competing in market
Price Spread
$8.02 – $8.02
per EA
7d Activity
avg -2.3% WoW · of 9 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Mylan Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Endothelin Receptor Antagonist class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
9 manufacturers producing AMBRISENTAN
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
AMBRISENTAN 10 MG TABLET | $8.0245 per EA | -2.25% |
AMBRISENTAN 10 MG TABLET | $8.0245 per EA | -2.25% |
AMBRISENTAN 10 MG TABLET | $8.0245 per EA | -2.25% |
AMBRISENTAN 10 MG TABLET | $8.0245 per EA | -2.25% |
AMBRISENTAN 10 MG TABLET | $8.0245 per EA | -2.25% |
AMBRISENTAN 10 MG TABLET | $8.0245 per EA | -2.25% |
AMBRISENTAN 10 MG TABLET | $8.0245 per EA | -2.25% |
AMBRISENTAN 10 MG TABLET | $8.0245 per EA | -2.25% |
AMBRISENTAN 10 MG TABLET | $8.0245 per EA | -2.25% |
Frequently Asked Questions
What is Ambrisentan used to treat?
Ambrisentan is used to treat pulmonary hypertension, per the National Library of Medicine's MED-RT classification.
When did Ambrisentan become available as a generic?
FDA approved the first generic Ambrisentan (ANDA) on Mar 28, 2019. The Orange Book currently lists 16 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Ambrisentan?
In 2024, Medicare Part D spent $268 million on Ambrisentan across 65,000 claims for 8,083 beneficiaries.
How many Ambrisentan products are on the market?
The Ambrisentan drug market contains 9 NDCs from 9 manufacturers — 9 generic and 0 brand products.
What is the price range for Ambrisentan?
NADAC reference prices for Ambrisentan range from $8.0245 to $8.0245 per EA.
Which manufacturers make Ambrisentan?
9 manufacturers list Ambrisentan in NADAC. Ranked by number of NDCs, the largest are Mylan Pharmaceuticals Inc. (1), Actavis Pharma, Inc. (1), Sigmapharm Laboratories LLC (1), Sun Pharmaceutical Industries Inc. (1), Aurobindo Pharma Limited (1).
How has the price of Ambrisentan changed recently?
Over the past 7 days, 0 Ambrisentan NDCs rose and 9 fell, with a market-wide average change of -2.3%.